Sensing and signalling viral infection in Drosophila
The programs inclusion criteria are: 40 years, diabetic kidney disease or T1D 10 years with additional CVRF
Despite the widespread use of lipotropic injections, there is a lack of proper research evaluating their efficacy and safety
Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens
Average weight loss during this phase ranges from 4 to 10 pounds, though individual variation is significant
Just dropped from Telanganas Drugs Control Administration: A sharp public advisory on Semaglutide formulations right as the patent cliff hit in March 2026